Adenovirus vector-mediated expression of TMEM166 inhibits human cancer cell growth by autophagy and apoptosis in vitro and in vivo.

Ying Chang,Yanjun Li,Jia Hu,Jinhai Guo,Dong Xu,Hong Xie,Xiaodong Lv,Taiping Shi,Yingyu Chen
DOI: https://doi.org/10.1016/j.canlet.2012.08.032
IF: 9.756
2013-01-01
Cancer Letters
Abstract:TMEM166 is a novel programmed cell death-related molecule. In this report, we constructed a recombinant adenovirus 5-TMEM166 vector (Ad5-TMEM166) and evaluated its expression and anti-tumor activities in vitro and in vivo. Cell viability analysis revealed that the adenovirus-mediated increase of TMEM166 inhibited tumor cell growth in a dose- and time-dependent manner. This inhibitory effect was mediated by both autophagy (via inhibition of mTOR and activation of p70S6K) and apoptosis (via caspase-3 activation), both of which contributed to cell death and suppression of tumorigenicity. Our data indicated that Ad5-TMEM166 may be a novel gene therapy candidate for cancer.
What problem does this paper attempt to address?